In situ ozone data for evaluation of the laser absorption spectrometer ozone remote sensor: 1979 southeastern Virginia urban plume study summer field program

Ozone data from the 1979 Southeastern Virginia Urban Study (SEV-UPS) field program are presented. The SEV-UPS was conducted for evaluation of an ozone remote sensor, the Laser Absorption Spectrometer. During the measurement program, remote-sensor evaluation was in two areas; (1) determination of the remote sensor's accuracy, repeatability, and operational characteristics, and (2) demonstration of the application of remotely sensed ozone data in air-quality studies. Data from six experiments designed to provide in situ ozone data for evaluation of the sensor in area 1, above, are presented. Experiments consisted of overflights of a test area with the remote sensor aircraft while in situ measurements with a second aircraft and selected surface stations provided correlative ozone data within the viewing area of the remote sensor

SBASI: Actuated pyrotechnic time delay initiator

A precision pyrotechnic time delay initiator for missile staging was developed and tested. Incorporated in the assembly is a single bridgewire Apollo standard initiator (SBASI) for initiation, a through-bulkhead-initiator to provide isolation of the SBASI output from the delay, the pyrotechnic delay, and an output charge. An attempt was made to control both primary and secondary variables affecting functional performance of the delay initiator. Design and functional limit exploration was performed to establish tolerance levels on manufacturing and assembling operations. The test results demonstrate a 2% coefficient of variation at any one temperature and an overall 2.7% coefficient of variation throughout the temperature range of 30 to 120 F. Tests were conducted at simulated operational altitude from sea level to 200,000 feet

Occupational safety considerations with hydrazine fuels

A simple pharmacokinetic model and a specially designed dermal vapor exposure chamber which provides respiratory protection were used to determine the rate of penetration of hydrazine and 1,1-dimethylhydrazine (UDMH) vapor through the skin of rats. Parameters for the pharmacokinetic model were determined from intravenous and inhalation exposure data. The model was then used to estimate the skin permeation coefficient for hydrazine or UDMH vapor from the dermal-vapor exposure data. This analysis indicates that UDMH vapor has a relatively high permeability through skin (0.7 cm/hr), a value somewhat higher than was obtained for hydrazine by the same procedure (0.09 cm/hr). Based on these skin permeability results, a skin-only vapor exposure limit giving protection equivalent to the inhalation Threshold Limit Value (TLV) could be calculated. The current TLV's for UDMH and hydrazine are 0.5 and 0.1 ppm, respectively. The corresponding skin-only TLV equivalents, for personnel wearing respiratory protection, are 32 ppm for UDMH and 48 ppm for hydrazine. Should the proposed lowering to the TLV's for these compounds to 0.01 ppm be adopted, the equivalent skin-only TLV's would become 0.64 ppm for UDMH and 4.8 for hydrazine

In situ ozone data for comparison with laser absorption remote sensor: 1980 PEPE/NEROS program

Several sets of in situ ozone (O3) measurements were made by a NASA aircraft in support of the laser absorption spectrometer (LAS) remote sensor. These measurements were designed to provide comparative O3 data for the LAS sensor. The LAS, which was flown on a second aircraft, remotely measured the vertical burden of O3 from the aircraft to the surface. In situ results of the air quality (O3 and B sub scat) and meteorological (temperature and dewpoint) parameters for three correlative missions are presented. The aircraft flight plans, in situ concentration profiles and vertical burdens, and measurement errors are summarized

Comparison of 32-site exact diagonalization results and ARPES spectral functions for the AFM insulator Sr2CuO2Cl2Sr_2CuO_2Cl_2

We explore the success of various versions of the one-band t-J model in explaining the full spectral functions found in angle-resolved photoemission spectra for the prototypical, quasi two-dimensional, tetragonal, antiferromagnetic insulator $Sr_2CuO_2Cl_2$. After presenting arguments justifying our extraction of $A(k,\omega)$ from the experimental data, we rely on exact-diagonalization results from studies of a square 32-site lattice, the largest cluster for which such information is presently available, to perform this comparison. Our work leads us to believe that (i) a one-band model that includes hopping out to third-nearest neighbours, as well three-site, spin-dependent hopping, can indeed explain not only the dispersion relation, but also the quasiparticle lifetimes -- only in the neighbourhood of $k = (\pi/2,0)$ do we find disagreement; (ii) an energy-dependent broadening function, $\Gamma (E) = \Gamma_0 + A E$, is important in accounting for the incoherent contributions to the spectral functions.Comment: 8 pages, Revtex

PROXIMO-DISTAL INCREASE OF ENZYMIC ACTIVITY IN THE DORSAL SPINAL TRACTS *

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/65919/1/j.1471-4159.1964.tb06151.x.pd

Rothamsted Conference RC No 11 : the making of new grassland experiences of practical farmers

RESP-74

Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence

BACKGROUND: Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated by using longitudinal specimens from persons with incident HIV infections, but questions remain about its accuracy. We sought to assess its performance in three longitudinal cohorts from Thailand where HIV-1 CRF01_AE and subtype B' dominate the epidemic. DESIGN: BED testing was conducted in two longitudinal cohorts with only incident infections (a military conscript cohort and an injection drug user cohort) and in one longitudinal cohort (an HIV-1 vaccine efficacy trial cohort) that also included long-term infections. METHODS: Incidence estimates were generated conventionally (based on the number of annual serocoversions) and by using BED test results in the three cohorts. Adjusted incidence was calculated where appropriate. RESULTS: For each longitudinal cohort the BED incidence estimates and the conventional incidence estimates were similar when only newly infected persons were tested, whether infected with CRF01_AE or subtype B'. When the analysis included persons with long-term infections (to mimic a true cross-sectional cohort), BED incidence estimates were higher, although not significantly, than the conventional incidence estimates. After adjustment, the BED incidence estimates were closer to the conventional incidence estimates. When the conventional incidence varied over time, as in the early phase of the injection drug user cohort, the difference between the two estimates increased, but not significantly. CONCLUSIONS: Evaluation of the performance of incidence assays requires the inclusion of a substantial number of cohort-derived specimens from individuals with long-term HIV infection and, ideally, the use of cohorts in which incidence remained stable. Appropriate adjustments of the BED incidence estimates generate estimates similar to those generated conventionally